Immediate Impact

64 standout
Sub-graph 1 of 24

Citing Papers

Global Burden, Risk Factor Analysis, and Prediction Study of Ischemic Stroke, 1990–2030
2023 Standout
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
2 intermediate papers

Works of S Schwaag being referenced

Botulinum Toxin A in the Prophylactic Treatment of Migraine – A Randomized, Double-Blind, Placebo-Controlled Study
2004
The Association Between Migraine and Juvenile Stroke: A Case‐Control Study
2003

Author Peers

Author Last Decade Papers Cites
S Schwaag 314 140 153 155 7 384
Alexandra Rahmann 330 119 214 178 12 455
Leah R. MacClellan 249 125 40 92 8 435
GE Tietjen 297 61 58 113 7 350
Aftab Alam 392 41 123 223 11 449
Ted E Roberts 248 147 112 137 7 399
A. Elkind 388 60 258 264 8 457
A. Testi 199 44 74 99 7 424
B. Lee Peterlin 230 29 84 115 8 368
Peter J. McAllister 360 111 189 252 13 423
M. Fischera 353 19 132 208 5 425

All Works

Loading papers...

Rankless by CCL
2026